11 August 2015 | News
L-Day: Syngene shares soar superb
Dr Kiran Mazumdar-Shaw, CMD, Biocon
Shares of Syngene International, a CRO and a subsidiary of biopharmaceutical behemoth Biocon, were listed at Rs 295 today, against its issue price of Rs 250 per share, on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Its shares opened at 18% higher, and hit a high of Rs 315 on BSE, up by 26%.
In July 2015, through its Initial Public Offering (IPO), Syngene raised INR 550 crore, and was subscribed more than 32-times.